Results 361 to 370 of about 399,723 (373)
Some of the next articles are maybe not open access.
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
Nature Reviews Clinical Oncology, 2015Rinath M Jeselsohn +2 more
exaly
Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Nature Reviews Molecular Cell Biology, 2018Iván M Moya, Georg Halder
exaly
STATs in cancer inflammation and immunity: a leading role for STAT3
Nature Reviews Cancer, 2009Hua Yu
exaly
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
Nature Medicine, 2001Olivier Nicole +2 more
exaly
STATs: transcriptional control and biological impact
Nature Reviews Molecular Cell Biology, 2002David E Levy
exaly
Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy
Nature Reviews Clinical Oncology, 2018Mark J Smyth +2 more
exaly
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Nature Reviews Cancer, 2014Hua Yu
exaly
Regulation of type I interferon responses
Nature Reviews Immunology, 2013Lionel B Ivashkiv, Laura Donlin
exaly
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Nature Reviews Molecular Cell Biology, 2011Marc Montminy
exaly
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Nature Reviews Drug Discovery, 2019, Geoffrey Wells, John D Hayes
exaly